Company profile
Bioxydyn Limited
Bioxydyn - Imaging Biomarker Services
Bioxydyn Limited is a UK company with status active founded in 2009.
Latest accounts
Financial period: 1 Dec 2023 to 30 Nov 2024
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQ0MjIwMjAwN2FkaXF6a2N4
Published 06 Nov 2024 12:07
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQzMTc4MTQzMmFkaXF6a2N4
Published 10 Aug 2024 08:01
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Oxygen enhanced lung MRI - towards clinical application
1 Mar 2019 to 31 Mar 2021
"The lung is poorly served by non-ionising or low-dose imaging technologies. Thoracic CT scanning is the main technique available, but does not permit routine follow-up or longitudinal monitoring because of the unacceptably high radiation dose, especially in children. Bioxydyn Ltd is an imaging services business offering quantitative MRI biomarkers for ph...
3D functional oxygen-enhanced lung imaging
1 Jun 2013 to 31 Dec 2014
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease, characterized by airflow obstruction to the lungs, interfering with normal breathing. It is one of the most common respiratory diseases and the WHO predicts it to be the 3rd leading cause of death worldwide by 2020. Early clinical diagnosis is critical to prevent further deteri...